MedTrace Logo

Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer.

NCT04823377 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 364

Last updated 2025-11-28

No results posted yet for this study

Summary

Sequential comparative prospective interventional study evaluating the impact of the use of an optimization device of the decision of cancer treatment on aggressiveness of end of life care. Comparison between a first period, period (A), of care as usual and a second period, period (B), of systematic and iterative use of a device for optimizing the decision to continue an anti-cancer treatment.

Conditions

Interventions

OTHER

Usual care

Patients receiving systemic anticancer treatment in their last days of life

OTHER

Optimization of the medical decision

Impact of the use of an optimization device of the decision of cancer treatment on aggressiveness of end of life care

Sponsors & Collaborators

  • Institut Curie

    lead OTHER

Principal Investigators

  • Marie-Ange MASSIANI, MD · Institut Curie

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-24
Primary Completion
2026-09-23
Completion
2027-09-23

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04823377 on ClinicalTrials.gov